Healthcare

‘Historic’ White House Announcement on Autism and Tylenol Causes Confusion

On Monday, President Donald Trump stood beside the “Make America Healthy Again” team for a “historic” announcement on autism. Back in April, Health and Human Services Secretary Robert F. Kennedy Jr. had promised to reveal what was causing “the autism epidemic” by September. 

At the start of this month, people close to the MAHA movement suggested that Kennedy’s upcoming autism announcement would link Tylenol use during pregnancy with the condition. Researchers worried it would veer into vaccines. Both Kennedy and Trump have spread misinformation about an association between vaccines and autism in the past, despite many rigorous studies refuting any link

Ann Bauer at the University of Massachusetts-Lowell, an epidemiologist who co-wrote a recent analysis about Tylenol and autism, told me, “I was sick to my stomach,” worrying that Kennedy would distort her team’s conclusions. She also feared scientists would reject her team’s measured concerns about Tylenol in a backlash against politicized or misleading remarks. 

Bauer and her colleagues had reviewed 46 studies on Tylenol, autism, and attention-deficit/hyperactivity disorder. Many found no link, while some suggested Tylenol might occasionally exacerbate other potential causes of autism, such as genetics. 

Since Tylenol is the only safe painkiller for use during pregnancy and fevers during pregnancy can be agonizing as well as dangerous, the team suggested judicious use of the medicine until the science was settled. 

That’s not what Trump advised. “Don’t take Tylenol,” he said. “Don’t give Tylenol to the baby. When the baby’s born, they throw it at you. Here, throw, give him a couple of Tylenol. They give him a shot. They give him a vaccine. And every time they give him a vaccine, they’re throwing Tylenol. And some of these babies, they, you know, they, they’re long born, and all of a sudden, they’re gone.” 

In emailed statements, HHS and White House spokespeople said Trump is using “gold-standard science” to address rising autism rates. 

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, called Trump’s comments dangerous. Centers for Disease Control and Prevention scientists told me they were never asked to brief Kennedy or the White House on autism, or to review the recommendations. Had researchers been asked, they would have explained that no single drug, chemical, or other environmental factor is strongly linked to the developmental disorder. 

Quick fixes — the kind promised by Kennedy — won’t make a dent, Tager-Flusberg said. “We know genetics is the most significant risk factor,” she said, “but you can’t blame Big Pharma for genetics, and you can’t build a political movement on genetics research and ride to victory.” 

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

Picture of John Doe
John Doe

Sociosqu conubia dis malesuada volutpat feugiat urna tortor vehicula adipiscing cubilia. Pede montes cras porttitor habitasse mollis nostra malesuada volutpat letius.

Related Article

Leave a Reply

Your email address will not be published. Required fields are marked *

X
"Hello! Let’s get started on your journey with us."
Site SearchBusiness ServicesBusiness Services

Meet Eve: Your AI Training Assistant

Welcome to Enlightening Methodology! We are excited to introduce Eve, our innovative AI-powered assistant designed specifically for our organization. Eve represents a glimpse into the future of artificial intelligence, continuously learning and growing to enhance the user experience across both healthcare and business sectors.

In Healthcare

In the healthcare category, Eve serves as a valuable resource for our clients. She is capable of answering questions about our business and providing "Day in the Life" training scenario examples that illustrate real-world applications of the training methodologies we employ. Eve offers insights into our unique compliance tool, detailing its capabilities and how it enhances operational efficiency while ensuring adherence to all regulatory statues and full HIPAA compliance. Furthermore, Eve can provide clients with compelling reasons why Enlightening Methodology should be their company of choice for Electronic Health Record (EHR) implementations and AI support. While Eve is purposefully designed for our in-house needs and is just a small example of what AI can offer, her continuous growth highlights the vast potential of AI in transforming healthcare practices.

In Business

In the business section, Eve showcases our extensive offerings, including our cutting-edge compliance tool. She provides examples of its functionality, helping organizations understand how it can streamline compliance processes and improve overall efficiency. Eve also explores our cybersecurity solutions powered by AI, demonstrating how these technologies can protect organizations from potential threats while ensuring data integrity and security. While Eve is tailored for internal purposes, she represents only a fraction of the incredible capabilities that AI can provide. With Eve, you gain access to an intelligent assistant that enhances training, compliance, and operational capabilities, making the journey towards AI implementation more accessible. At Enlightening Methodology, we are committed to innovation and continuous improvement. Join us on this exciting journey as we leverage Eve's abilities to drive progress in both healthcare and business, paving the way for a smarter and more efficient future. With Eve by your side, you're not just engaging with AI; you're witnessing the growth potential of technology that is reshaping training, compliance and our world! Welcome to Enlightening Methodology, where innovation meets opportunity!

[wpbotvoicemessage id="402"]